Abstract:To explore the mechanism of impairment and defense of oxidative stress in cavernous mitochondria of diabetic rats.Adult male SD rats(n=42)were randomly divided into normal control group(n=10) and experimental group(n=32). The diabetic model rats induced by streptozotocin were randomly divided into diabetes group(n=13) and therapeutic group with reduced glutathione (GSH) treatment(n=12). Eight weeks later, erectile function was assessed by measuring the rise in intracavernous pressure (ICP) of the rats following cavernous nerve eletrostimulation before the rats were sacrificed. The levels of malondialdehyde (MDA) and the activities of superoxide dismutase (SOD) in cavernous tissue were detected. The masson staining was used to show the structure of the rat penis. Mitochondrial transmembrane potential was detected.A significant decrease in ICP was recorded in the diabetic rats [(50.80 ± 9.80)vs.(90.42 ± 7.02) mmHg,P<0.05], with improvement measured in the rats receiving GSH [(74.20 ± 5.69)vs.(50.80 ± 9.80)mmHg, P<0.05]. The levels of MDA increased remarkably [(6.15 ± 1.07)vs.(3.52 ± 0.94)mmol/g protein, P<0.01] and the activities of SOD decreased significantly[(73.34 ± 6.56)vs.(114.22 ± 6.34)U/mg protein, P<0.05)] in cavernous tissue of the diabetes group. Mitochondria transmembrane potential was decreased [(727.98 ± 68.33)vs.(1223.15 ± 222.92),P<0.01]. A remarkable decrease in MDA [(3.90 ± 0.96)vs.(6.15 ± 1.07)mmol/g protein, P<0.05] and increase in SOD[(95.74 ± 4.65)vs.(73.34 ± 6.56)U/mg protein,P<0.05] were observed in GSH treatment group. Meanwhile, the morphology changes of cavernous tissue and the decrease of mitochondria transmembrane potential were inhibited[(930.30 ± 48.36) vs.727.98 ± 68.33),P<0.05], in diabetic rats with GSH treatment.Hyperglycemia could cause oxidative stress in the cavernous tissue of diabetic rats and this impairment could contribute to diabetic erectile dysfunction; Oxidant treatment could attenuate oxidative stress by improving the function of mitochondria in cavernous tissue. Oxidative stress plays an important role in diabetic erectile dysfunction (DED) and our study might provide a new insight into the prevention and treatment of DED.

Oxidative Stress and Diabetic Erectile Dysfunction

The Multifaceted Nature of Diabetic Erectile Dysfunction: Uncovering the Intricate Mechanisms and Treatment Strategies

The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction

Mechanisms of oxidative stress-induced damage and its protection in cavernous mitochondria of diabetic rats]

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Oxidative Stress and Erectile Dysfunction: Pathophysiology, Impacts, and Potential Treatments

The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy

Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment

Oxidative Stress and Its Regulation in Diabetic Retinopathy

Advanced glycation end products and diabetic erectile dysfunction

Oxidative stress and stress signaling: menace of diabetic cardiomyopathy

Oxidative Stress and Diabetic Cardiomyopathy: A Brief Review

Oxidative stress as a culprit in diabetic kidney disease

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus

Role of Oxidative Stress in Diabetic Cardiomyopathy

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

Advances in Pathogenesis and Treatment of Diabetic Erectile Dysfunction

‘Oxidative stress’-A new target in the management of diabetes mellitus

Systematic Understanding of Pathophysiological Mechanisms of Oxidative Stress-Related Conditions—Diabetes Mellitus, Cardiovascular Diseases, and Ischemia–Reperfusion Injury